OPKO to sell BioReference assets to Labcorp for $722M
Alpha Vantage · TradingView · · AI-summarised by FinFlash
OPKO Health agreed to sell certain BioReference Health assets to Labcorp for $722 million in cash, plus an earnout of up to Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context